Evidence map›Paper›PMID 41564123›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Structural characterization of the HDV virion and its ribonucleoprotein.

Samuel Itskanov, Beatrice Ary, Upasana Mehra, Irene Lew, Nikolai Novikov, Uli Schmitz, Meghan M Holdorf, Rudolf K Beran, Eric B Lansdon

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Samuel ItskanovStructural Biology & Chemistry, Gilead Sciences, Inc., Foster City, CA 94404.ORCID 0000-0003-0705-2359
Beatrice AryDiscovery Virology, Gilead Sciences, Inc., Foster City, CA 94404.
Upasana MehraDiscovery Sciences & Tech, Gilead Sciences, Inc., Foster City, CA 94404.
Irene LewDiscovery Virology, Gilead Sciences, Inc., Foster City, CA 94404.ORCID 0000-0003-0153-1236
Nikolai NovikovProtein Therapeutics, Gilead Sciences, Inc., Foster City, CA 94404.
Uli SchmitzStructural Biology & Chemistry, Gilead Sciences, Inc., Foster City, CA 94404.
Meghan M HoldorfDiscovery Virology, Gilead Sciences, Inc., Foster City, CA 94404.
Rudolf K BeranDiscovery Virology, Gilead Sciences, Inc., Foster City, CA 94404.ORCID 0000-0001-5435-8014
Eric B LansdonStructural Biology & Chemistry, Gilead Sciences, Inc., Foster City, CA 94404.ORCID 0000-0001-9461-1475

Funding

Gilead Sciences (Gilead) N/A
6 · The paper itself

Abstract

Hepatitis D virus (HDV) is a small RNA satellite virus of hepatitis B virus (HBV) which encodes a single protein, HDV delta antigen (HDAg), that is required for replication. Viral replication occurs independently from HBV and relies primarily on host RNA polymerase(s). Bulevirtide, a viral entry inhibitor, is the only approved treatment for chronic HDV but has a low cure rate as a monotherapy, and most patients rebound following cessation of therapy. It is likely that an inhibitor targeting HDV replication is necessary to achieve HDV cure, but the paucity of HDV-derived elements and limited understanding of HDV replication presents a significant therapeutic challenge. Understanding the precise mechanism of interactions between HDAg and viral RNA, and how it is packaged within the virion can inspire structure-guided drug design targeting replication. Using cryoelectron tomography and single particle cryoelectron microscopy, we present reconstructions of the virion and viral RNPs. We observed multiple binding configurations in vitro that suggest a propensity to arrange four RNA segments around repeating units of HDAg in a ladder-like formation. The oligomerization domains of a homo-octameric HDAg complex are directly involved in RNA binding by utilizing the vertices and sides of its square-shaped architecture to bind RNA in a sequence-promiscuous fashion. Structure-function analysis reveals that these RNA contact sites are important for viral replication and their disruption may be a potential avenue for next-generation antivirals to treat HDV.

Indexed as

Hepatitis Delta VirusRibonucleoproteinsVirionCryoelectron MicroscopyHepatitis delta AntigensHumansModels, MolecularRNA, ViralVirus ReplicationHepatitis delta AntigensRibonucleoproteinsRNA, Viralcryo-EMcryo-ETHDVribonucleoprotein

Identifiers

PMID41564123
PMCPMC12846810

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.